JP2005513106A5 - - Google Patents

Download PDF

Info

Publication number
JP2005513106A5
JP2005513106A5 JP2003554209A JP2003554209A JP2005513106A5 JP 2005513106 A5 JP2005513106 A5 JP 2005513106A5 JP 2003554209 A JP2003554209 A JP 2003554209A JP 2003554209 A JP2003554209 A JP 2003554209A JP 2005513106 A5 JP2005513106 A5 JP 2005513106A5
Authority
JP
Japan
Prior art keywords
heparin
use according
hyaluronic acid
pharmaceutical composition
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003554209A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005513106A (ja
Filing date
Publication date
Priority claimed from DE10161149A external-priority patent/DE10161149B4/de
Application filed filed Critical
Publication of JP2005513106A publication Critical patent/JP2005513106A/ja
Publication of JP2005513106A5 publication Critical patent/JP2005513106A5/ja
Pending legal-status Critical Current

Links

JP2003554209A 2001-12-12 2002-12-11 ヘパリンを保有する眼薬剤 Pending JP2005513106A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10161149A DE10161149B4 (de) 2001-12-12 2001-12-12 Verwendung von Heparin-haltigem Ophthalmikum
PCT/DE2002/004526 WO2003053452A1 (de) 2001-12-12 2002-12-11 Heparin-haltiges ophthalmikum

Publications (2)

Publication Number Publication Date
JP2005513106A JP2005513106A (ja) 2005-05-12
JP2005513106A5 true JP2005513106A5 (cg-RX-API-DMAC7.html) 2006-02-09

Family

ID=7709005

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003554209A Pending JP2005513106A (ja) 2001-12-12 2002-12-11 ヘパリンを保有する眼薬剤

Country Status (11)

Country Link
US (1) US20050043271A1 (cg-RX-API-DMAC7.html)
EP (1) EP1453523B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005513106A (cg-RX-API-DMAC7.html)
CN (1) CN1604784A (cg-RX-API-DMAC7.html)
AT (1) ATE318607T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002357972A1 (cg-RX-API-DMAC7.html)
CA (1) CA2468775A1 (cg-RX-API-DMAC7.html)
DE (2) DE10161149B4 (cg-RX-API-DMAC7.html)
ES (1) ES2259727T3 (cg-RX-API-DMAC7.html)
MX (1) MXPA04005390A (cg-RX-API-DMAC7.html)
WO (1) WO2003053452A1 (cg-RX-API-DMAC7.html)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7455855B2 (en) * 2000-04-03 2008-11-25 Santen Pharmaceutical Co., Ltd. Delivering substance and drug delivery system using the same
US7235556B2 (en) 2003-04-16 2007-06-26 Alcon, Inc. Methods of treating dry eye disorders
DE10360425A1 (de) * 2003-12-19 2005-07-28 Ursapharm Arzneimittel Gmbh & Co. Kg Verwendung von Hyaluronsäure, Hyaluronat und/oder deren Derivate zur Herstellung einer pharmazeutischen Zusammensetzung
JP2005187407A (ja) * 2003-12-25 2005-07-14 Lion Corp アレルギー眼疾患用眼科組成物
DE102004002001A1 (de) * 2004-01-14 2005-08-11 Reinmüller, Johannes, Dr.med. Mittel zur Behandlung von entzündlichen Erkrankungen
DE102005035986B4 (de) * 2005-07-28 2009-10-15 Bausch & Lomb Incorporated Steriles tropfbares mehrphasiges emulgatorfreies ophthalmisches Präparat
DE102005055275A1 (de) * 2005-11-17 2007-05-24 Ursapharm Arzneimittel Gmbh & Co. Kg Phosphatfreie pharmazeutische Zusammensetzung sowie deren Verwendung
DE102006049091A1 (de) * 2006-10-18 2008-04-24 Dr. Gerhard Mann Chem.-Pharm. Fabrik Gmbh Emulgatorfreies ophthalmisches Präparat enthaltend Pflanzenöl
FR2919185B1 (fr) * 2007-07-23 2010-09-10 Ard Sa Utilisation d'acide hyaluronique pour la preparation de compositions destinees a l'amelioration notamment de l'etat des muqueuses
PL2346573T3 (pl) * 2008-11-20 2014-12-31 Laboratori Derivati Organici S P A Wykorzystanie siarczanu heparanu w kosmetycznych i dermatologicznych preparatach
WO2010144874A2 (en) 2009-06-12 2010-12-16 University Of Southern California Clusterin pharmaceuticals and treatment methods using the same
FR2962044B1 (fr) * 2010-04-21 2013-02-22 Horus Pharma Emulsion lacrymimetique
JP2016185940A (ja) * 2014-06-10 2016-10-27 ロート製薬株式会社 眼科用組成物
DE102016203696A1 (de) * 2016-03-07 2017-09-07 Ursapharm Arzneimittel Gmbh Ophthalmologische Zusammensetzung
ES2909998T3 (es) * 2016-10-14 2022-05-11 I Com Medical Gmbh Método para establecer, restablecer y preservar la homeostasis de la superficie ocular
EP3644966A4 (en) * 2017-06-29 2021-03-24 Advaite LLC TREATMENT AND DIAGNOSIS OF EYE SURFACE DISORDERS
KR20200083974A (ko) * 2017-09-05 2020-07-09 엑셀 메드, 엘엘씨 허혈 치료용 헤파린 조성물
EA202091725A1 (ru) * 2018-01-18 2020-10-12 Фаэс Фарма С.А. Офтальмические композиции, содержащие биластин, бета-циклодекстрин и по крайней мере одно желатинирующее вещество
US12303527B2 (en) 2018-04-18 2025-05-20 i.com medical GmbH High molecular weight hyaluronic acid for treatment and prevention of severe ocular surface disease
US12268706B2 (en) 2019-01-31 2025-04-08 i.com medical GmbH Hyaluronic acid for relief of idiopathic ocular pain
CN116139067B (zh) * 2021-11-22 2024-03-22 华熙生物科技股份有限公司 透明质酸锌形成凝胶的方法及含有透明质酸锌的滴眼凝胶及其制备
CN117427149A (zh) * 2022-07-14 2024-01-23 优微(珠海)生物科技有限公司 护眼组合物、含该护眼组合物的产品、制备方法和应用
WO2024024920A1 (ja) * 2022-07-29 2024-02-01 マルホ株式会社 眼科用組成物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1730M (fr) * 1962-01-17 1963-03-18 Charles Riviere Nouvelle composition de collyre.
DE3440352A1 (de) * 1984-11-05 1986-05-07 Dr. Thilo & Co GmbH, 8029 Sauerlach Dry-eye-packung
CA1295238C (en) * 1986-04-04 1992-02-04 David R. Gibson Methods and materials for use in corneal wounds
JPS6479103A (en) * 1987-06-09 1989-03-24 Lion Corp External preparation
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
JPH02167233A (ja) * 1988-11-10 1990-06-27 Kiyoshi Kita 眼内手術補助剤
US5141741A (en) * 1988-12-09 1992-08-25 Lion Corporation Anti-sunburn skin-care preparation
US5358706A (en) * 1992-09-30 1994-10-25 Union Carbide Chemicals & Plastics Technology Corporation Muco-adhesive polymers
IT1273011B (it) * 1994-07-25 1997-07-01 Trhecnopharma S A Preparato oftalmico per l'uso come lacrima artificiale
DE19520575A1 (de) * 1995-06-06 1996-12-12 Permselect Ges Fuer Zellstrukt Hautwirksame Kombination von Mucopolysacchariden
DE19547972A1 (de) * 1995-12-21 1997-07-10 Weropharm Gmbh Heparin zur Prophylaxe und akuten Therapie der allergischen Konjunktivitis
CA2265767C (en) * 1997-07-11 2007-12-04 Nobuyuki Hanamura Stable pharmaceutical composition including 4,5-epoxy-morphinan derivative
US6348508B1 (en) * 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye

Similar Documents

Publication Publication Date Title
JP2006501133A5 (cg-RX-API-DMAC7.html)
ES2460570T3 (es) Composiciones oftálmicas que contienen una combinación sinérgica de tres polímeros
CN101405009B (zh) 包含黄原胶和葡萄糖的眼科组合物
MXPA04005387A (es) Composicion farmaceutica para uso en oftalmologia y rinologia.
JP2007513959A5 (cg-RX-API-DMAC7.html)
CN101925347A (zh) 多糖凝胶组合物及持续递送药物的方法
CN101658491B (zh) 一种治疗角膜碱烧伤的羊膜滴眼液
US20160361254A1 (en) Injectable aqueous ophthalmic composition and method of use therefor
KR20000076347A (ko) 눈의 전방에서의 의약의 제어방출
JP2005513106A (ja) ヘパリンを保有する眼薬剤
JP2011037891A5 (cg-RX-API-DMAC7.html)
ES2361459A1 (es) Gel de quitosano para aplicaciones dermatológicas, proceso de obtención y uso del mismo.
JP2018531292A6 (ja) インサイチュでゲルを形成する医薬製剤
CN107847604A (zh) 眼用原位凝胶处方
RU2011152518A (ru) Применение композиции для лечения мукозита
JP2011513393A5 (cg-RX-API-DMAC7.html)
JP2020525416A5 (cg-RX-API-DMAC7.html)
CN1302812C (zh) 含海藻糖和玻璃酸的眼部用药传递系统及其制备方法
ES2850577T3 (es) Conjugado de ácido hialurónico
ES2648414T3 (es) Sales de oro y plata de glicosaminoglicanos parcialmente despolimerizadas
WO2012119261A1 (en) Enhanced artificial mucus composition comprising hyaluronan for the treatment of rhinitis
US10463628B2 (en) Glycosaminoglycan-coated metallic nanoparticles and uses thereof
CN1403158A (zh) 含壳聚糖衍生物的滴眼液
CA2472093A1 (en) Use of sulfated glycosaminoglycans for establishing effective labor in women
JP2007530226A5 (cg-RX-API-DMAC7.html)